(Q83540883)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21378302%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

Clopidogrel hyporesponsiveness and the FDA boxed warning: detection and management of patients with genetic polymorphisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21378302%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

1 reference

Elizabeth Perry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21378302%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

1 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21378302%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Health-System Pharmacy

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21378302%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21378302%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21378302%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

529-532

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21378302%20AND%20SRC:MED&resulttype=core&format=json

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel

24 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

Molecular basis of ethnic differences in drug disposition and response

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

Cytochrome p-450 polymorphisms and response to clopidogrel

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angiop

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

Prasugrel versus clopidogrel in patients with acute coronary syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100422

31 March 2020

Identifiers

DOI

10.2146/AJHP100422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21378302%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference